{
  "raw_answer": "affected",
  "question": "Format answer for: Regarding patient 'AII-11' from family 'Family A': What is the clinical status of the patient?",
  "context": "Based on the information in the document:\n\nFor patient 'AII-11' from 'Family A':\n\nThe clinical status of patient AII-11 is described as follows:\n*   He was a 77-year-old man at the time of the report (Table 2 indicates a disease duration of 15 years and age at onset of 62, which would make him 77).\n*   He developed right upper limb rest tremor at age 62.\n*   His symptoms included resting tremor, bradykinesia, rigidity, gait disturbance, and postural instability.\n*   He showed a clinical response to levodopa, but experienced wearing off and levodopa-induced dyskinesia.\n*   He exhibited asymmetry at onset, orthostatic hypotension, incontinence, urinary urgency, and sleep benefit.\n*   He did not have dystonia at onset, hyperreflexia, other psychosis, or gaze palsy.\n*   At age 75 (after 13 years of disease), he underwent gastrostomy for progressive dysphagia.\n*   After the gastrostomy (at age 75), he developed cognitive dysfunction without hallucination.\n*   Brain MRI was within normal limits (WNL).\n*   Cardiac MIBG scintigraphy, performed when he was 76 years old, showed an H/M ratio (E/L) of 2.38/2.68 and a washout ratio of 4.15%.\n*   Single-photon emission computed tomography of cerebral blood flow showed no reduction in blood flow in the basal ganglia.\n*   He has the p.D620N mutation in the VPS35 gene.\n*   Table 2 indicates dementia as negative, though the text notes he developed cognitive dysfunction at age 75."
}